The Remote Monitoring of Gout Feasibility Study in Primary Care
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Diakonhjemmet Hospital
- Trial code
- NCT07490522
- Record updated
- 30 April 2026
- Original description
The goal of this feasibility study is to determine the feasibility of a patient self-management app (MinUrinsyregikt) for patients with gout. The primary objectives of the study are:Read full original descriptionShow less
The Self-management App 'MinUrinsyregikt' for Patients With Gout. The ReMonit Gout Feasibility Study in Primary Care
The goal of this feasibility study is to determine the feasibility of a patient self-management app (MinUrinsyregikt) for patients with gout. The primary objectives of the study are:
1. To determine the feasibility of a patient self-management app for patients with gout receiving GP follow-up. 2. To determine the feasibility of conducting a future randomised controlled trial to test the effectiveness of the app for patients with gout in primary care.
Participants will be asked to test the self-management app for 3 months. Data will be collected from the participants and their GPs.
Patients are eligible to be included in the study only if all the following criteria apply:; Adults ≥18 years of age at screening; Patients with a clinical diagnosis of gout; Serum urate level >360 µmol/L at inclusion; Indication for urate lowering therapy assessed by medical doctor; Having a smartphone/tablet; Patients are excluded from the study if any of the following criteria apply:; Pregnant or breastfeeding; Contraindication for urate lowering therapy; Does not understand Norwegian language; Major co-morbidities (e.g., malignancies, severe chronic kidney disease, severe mental disorders).